Krishna Institute of Medical Sciences Ltd
•Add ratio to table
ABOUT
AI Sector View
AI GENERATEDHealthcare
This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.
PROS
- Company has consistently been profitable over the last 5 years
- Company has delivered good sales growth of 24.0% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.63x)
- Working capital cycle has improved - days down from -17 to -28
CONS
- Recent results are weak - TTM profit is down 49.1% versus prior year
- Promoter holding has decreased over last 2 years: -6.3pp
- Free cash flow has been persistently negative
- Valuation is stretched - P/E of 158.1 is well above its own 5-year median (66.5)
- Total debt has risen sharply - up 69.8% year on year
- Company has delivered a poor profit growth of 3.3% over past five years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | 8850.00 | 60.90 | 127249.42 | 0.23 | 610.40 | 38.41 | 7043.50 | 20.56 | 21.73 | 15.70 |
| MAXHEALTH | 1037.20 | 69.29 | 100951.74 | 0.19 | 322.96 | 4.87 | 2366.17 | 16.70 | 14.97 | 25.29 |
| MANIPALHOS | 716.15 | 105.57 | 94200.74 | 0.00 | 2434.30 | — | 30906.30 | — | 13.93 | 23.83 |
| FORTIS | 887.30 | 63.93 | 66987.44 | 0.11 | 272.80 | 2.26 | 2545.03 | 17.46 | 14.07 | 21.28 |
| ASTERDM | 762.95 | 208.69 | 66504.25 | 0.39 | 29.28 | -68.70 | 1310.68 | 21.60 | 11.26 | 19.53 |
| MEDANTA | 1447.55 | 69.98 | 38920.53 | 0.03 | 157.25 | -1.09 | 1304.05 | 26.50 | 19.38 | 21.99 |
| NH | 1867.35 | 46.76 | 38161.31 | 0.24 | 207.27 | 5.37 | 2683.63 | 78.05 | 16.20 | 17.43 |
| KIMS | 768.85 | 158.06 | 32292.20 | 0.00 | 37.40 | -56.00 | 1179.50 | 35.33 | 11.51 | 19.03 |
| LALPATHLAB | 1909.40 | 59.14 | 32049.05 | 1.07 | 1705.00 | 1172.39 | 7977.00 | 1090.95 | 29.56 | 31.03 |
| AGARWALEYE | 507.00 | 108.33 | 16073.23 | 0.00 | 55.02 | 44.56 | 614.02 | 25.97 | 16.14 | 27.75 |
| VIJAYA | 1502.30 | 82.53 | 15473.35 | 0.13 | 53.10 | 37.61 | 230.98 | 22.83 | 30.28 | 42.66 |
| RAINBOW | 1443.40 | 51.37 | 14660.13 | 0.24 | 62.54 | 16.23 | 469.99 | 33.17 | 28.25 | 28.65 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 606 | 652 | 606 | 634 | 688 | 777 | 772 | 797 | 872 | 961 | 998 | 1,075 | 1,180 | |
| 449 | 475 | 459 | 475 | 509 | 559 | 585 | 599 | 679 | 757 | 799 | 868 | 1,140 | |
| Operating Profit | 157 | 177 | 147 | 159 | 179 | 218 | 187 | 198 | 193 | 204 | 199 | 206 | 39 |
| OPM % | 25.92% | 27.17% | 24.27% | 25.09% | 26.06% | 28.06% | 24.24% | 24.85% | 22.10% | 21.23% | 19.94% | 19.22% | 3.32% |
| 3 | 3 | 3 | 4 | 5 | 5 | 18 | 15 | 7 | 4 | 5 | -1 | 16 | |
| Interest | 9 | 9 | 12 | 16 | 18 | 20 | 26 | 27 | 33 | 45 | 57 | 68 | 83 |
| Depreciation | 32 | 33 | 35 | 46 | 39 | 41 | 45 | 53 | 53 | 66 | 79 | 85 | 101 |
| Profit before Tax | 119 | 139 | 102 | 100 | 127 | 162 | 135 | 134 | 114 | 97 | 69 | 52 | 57 |
| Tax % | 26.90% | 26.96% | 25.27% | 28.47% | 25.10% | 25.59% | 31.28% | 20.82% | 25.24% | 25.62% | 24.34% | 41.57% | 33.92% |
| Net Profit | 0 | 0 | 0 | 0 | 95 | 121 | 92 | 106 | 85 | 72 | 52 | 33 | 37 |
| 10.10 | 2.30 | 1.80 | 1.64 | 2.16 | 2.68 | 2.22 | 2.54 | 1.96 | 1.67 | 1.33 | 1.06 | 1.04 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 567 | 664 | 918 | 1,123 | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 | 4,212 | |
| 508 | 592 | 833 | 873 | 954 | 1,129 | 1,598 | 1,854 | 2,242 | 3,090 | 3,564 | |
| Operating Profit | 60 | 71 | 85 | 249 | 376 | 522 | 599 | 645 | 793 | 815 | 649 |
| OPM % | 10.49% | 10.76% | 9.22% | 22.22% | 28.25% | 31.60% | 27.27% | 25.81% | 26.13% | 20.86% | 15.40% |
| 3 | 34 | 6 | 6 | 10 | 20 | 52 | 16 | 43 | 15 | 24 | |
| Interest | 80 | 88 | 49 | 44 | 37 | 22 | 37 | 54 | 100 | 215 | 253 |
| Depreciation | 36 | 40 | 56 | 71 | 70 | 73 | 129 | 146 | 177 | 283 | 331 |
| Profit before Tax | -53 | -22 | -15 | 141 | 279 | 457 | 485 | 460 | 558 | 334 | 274 |
| Tax % | -33.79% | -117.78% | -222.98% | 18.11% | 26.36% | 24.75% | 24.56% | 26.90% | 25.68% | 27.52% | 30.05% |
| Net Profit | -71 | -48 | -49 | 115 | 205 | 344 | 366 | 336 | 415 | 242 | 192 |
| EPS | -14.21 | -9.41 | -6.71 | 15.87 | 26.42 | 41.88 | 42.03 | 38.75 | 9.61 | 6.04 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- 23%
- 5 Years:
- 24%
- 3 Years:
- 21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 25%
- 5 Years:
- 4%
- 3 Years:
- -10%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- 25%
- 3 Years:
- 23%
- 1 Year:
- 1%
RETURN ON EQUITY
- 10 Years:
- 3%
- 5 Years:
- 21%
- 3 Years:
- 17%
- Last Year:
- 11%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 74 | 74 | 78 | 80 | 80 | 80 | 80 | 80 |
| Minority Interest | 5 | 21 | 25 | 13 | 12 | 23 | 268 | 265 | 281 | 311 |
| -163 | -208 | 466 | 523 | 786 | 1,307 | 1,590 | 1,748 | 2,058 | 2,167 | |
| 211 | 304 | 336 | 368 | 316 | 250 | 670 | 1,324 | 2,531 | 4,175 | |
| Trade Payables | 79 | 95 | 104 | 123 | 132 | 130 | 174 | 197 | 269 | 323 |
| 582 | 648 | 109 | 92 | 110 | 114 | 119 | 206 | 457 | 575 | |
| Total Liabilities | 764 | 910 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,676 | 7,631 |
| 523 | 711 | 863 | 916 | 931 | 1,005 | 1,766 | 2,434 | 3,348 | 5,710 | |
| Capital Work in Progress | 64 | 0 | 0 | 2 | 9 | 21 | 477 | 600 | 1,214 | 606 |
| 15 | 0 | 0 | 0 | 0 | 332 | 68 | 157 | 99 | 103 | |
| 16 | 20 | 27 | 30 | 24 | 36 | 43 | 49 | 64 | 97 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 294 | 395 | 554 | |
| Cash & Bank | 8 | 11 | 10 | 46 | 284 | 190 | 66 | 49 | 80 | 75 |
| 138 | 168 | 213 | 200 | 184 | 319 | 481 | 236 | 475 | 486 | |
| Total Assets | 764 | 910 | 1,114 | 1,194 | 1,433 | 1,904 | 2,901 | 3,820 | 5,676 | 7,631 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 97 | 136 | 165 | 255 | 394 | 451 | 529 | 521 | 582 | 511 | |
| Cash from Investing | -70 | -64 | -110 | -125 | -354 | -412 | -547 | -753 | -1,116 | -1,452 |
| Cash from Financing | -8 | -39 | -27 | -44 | 10 | 61 | 20 | 217 | 543 | 940 |
| 5 | 3 | -3 | 32 | 12 | -26 | -95 | -15 | 9 | -1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
2026-09-10 - Krishna Institute of Medical Sciences Limited has informed the Exchange about entering into an Operations and Management Agreement with Sarvottam Health Care Private Limited, Kakinada, Andhra Pradesh
2026-09-07 - Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
2026-08-30 - Krishna Institute of Medical Sciences Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 27, 2026. Further, the company has informed the Exchange regarding voting results.
2026-08-27 - Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 27, 2026
2026-08-26 - Krishna Institute of Medical Sciences Limited has informed the Exchange about Clarification regarding article appearing in Dealstreetasia.com dated 25th August 2026 titled ChrysCapital- backed KIMS in talks to acquire stake in Renova Hospitals for $52 Million
2026-08-20 - Krishna Institute of Medical Sciences Limited has informed the Exchange about entering into an Operations and Management Agreement and Call Option Agreement with Aurevia Hospitals Private Limited (Formerly known as Golden Lan Solution Private Limited), Hyderabad, Telangana.
2026-08-20 - Krishna Institute of Medical Sciences Limited has informed the Exchange regarding allotment of 7702182 fully convertible warrants securities pursuant to Preferential Issue
2026-08-08 - Krishna Institute of Medical Sciences Limited has informed the Exchange about Transcript
2026-08-07 - Intimation of receipt of the In-principle Approval from BSE Limited and the National Stock Exchange of India Limited for the issue and allotment of 77,02,182 (Seventy-Seven Lakh Two Thousand One Hundred and Eighty-Two) warrants fully convertible into equity shares of face value of Rs. 2/- each, to promoters/promoter group on a preferential basis.
News
Recent coverage and analyst commentary for KIMS
Loading news…
AI Stock Analyst
Krishna Institute of Medical Sciences Ltd
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account